Firmenbeschreibung
Die Evotec SE zählt zu den weltweit führenden Wirkstoffforschungs- und -entwicklungsunternehmen. Die Firma ist auf neurale Erkrankungen, Schmerz, Stoffwechsel- und Entzündungskrankheiten sowie Onkologie spezialisiert. Das Kerngeschäft bildet die Wirkstoffforschung, die in Kooperation mit Partnerunternehmen aus der Pharma- und Biotechnologieindustrie realisiert wird. Unternehmen, die ihre Wirkstoffentwicklung auslagern wollen, werden hochwertige Lösungen und Dienstleistungen in diesem Bereich angeboten. Evotec übernimmt dabei alle Aktivitäten bis hin zur klinischen Entwicklung. Das Unternehmen unterhält langjährige Forschungsallianzen mit den größten Pharma-Unternehmen wie Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi oder Takeda sowie mit der Havard University zur Erforschung neuer Wirkstoffe.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | Novo Holdings A/S (10%),T. Rowe Price Group (10%),Mubadala Investment Company (7%) |
sharesOutstanding: | 176952700.0000 |
ceo: | Dr. Werner Lanthaler |
board: | Laetitia Rouxel, Dr. Cord Dohrmann, Dr. Craig Johnstone, Dr. Matthias Evers |
supervisoryBoard: | Prof. Dr. Iris Löw-Friedrich, Dr. Constanze Ulmer-Eilfort, Dr. Elaine Sullivan, Dr. Mario Polywka, Roland Sackers, Camilla Macapili Languille |
countryID: | 2 |
freeFloat: | 62.1900 |
faceValueCurrencyID: | 1 |
faceValueCurrency: | EUR |
sectorName: | Biotechnologie |
industryName: | Biotechnologie |
subsectorName: | Biotechnologie |
country: | Deutschland |
countryName: | Deutschland |
Kontakt
name: | Volker Braun |
phone: | +49-40-56081-775 |
fax: | +49-40-56081-222 |
email: | InvestorRelations@evotec.com |
irWebSite: | https://www.evotec.com/en/investor-relations |
Adresse
street: | Essener Bogen 7 |
city: | D-22419 Hamburg |
phone: | +49-40-56081-0 |
fax: | +49-40-56081-222 |
webSite: | www.evotec.com |
email: | info@evotec.com |
Finanzen (kurz)
year: | 2020 | cash: | 422.6000 |
balanceSheetTotal: | 1462.9000 | liabilities: | 740.1000 |
totalShareholdersEquity: | 722.8000 | sales: | 500.9000 |
bankLoans: | 48.5000 | investment: | 1.3000 |
incomeBeforeTaxes: | 25.8000 | netIncome: | 6.3000 |
cashFlow: | 136.0000 | employees: | 3355 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
year: | 2021 | cash: | 699.3000 |
balanceSheetTotal: | 2235.2000 | liabilities: | 857.5000 |
totalShareholdersEquity: | 1377.7000 | sales: | 618.0000 |
bankLoans: | 41.0000 | investment: | 2.3000 |
incomeBeforeTaxes: | 237.0000 | netIncome: | 215.5000 |
cashFlow: | 276.8000 | employees: | 3945 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
year: | 2022 | cash: | 415.1600 |
balanceSheetTotal: | 2257.2500 | liabilities: | 1070.0600 |
totalShareholdersEquity: | 1187.1800 | sales: | 751.4500 |
investment: | 8.3400 | incomeBeforeTaxes: | -153.9600 |
netIncome: | -175.6600 | employees: | 4952 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
Finanzen (kurz)
year: | 2020 |
cash: | 422.6000 |
balanceSheetTotal: | 1462.9000 |
liabilities: | 740.1000 |
totalShareholdersEquity: | 722.8000 |
sales: | 500.9000 |
bankLoans: | 48.5000 |
investment: | 1.3000 |
incomeBeforeTaxes: | 25.8000 |
netIncome: | 6.3000 |
cashFlow: | 136.0000 |
employees: | 3355 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
year: | 2021 |
cash: | 699.3000 |
balanceSheetTotal: | 2235.2000 |
liabilities: | 857.5000 |
totalShareholdersEquity: | 1377.7000 |
sales: | 618.0000 |
bankLoans: | 41.0000 |
investment: | 2.3000 |
incomeBeforeTaxes: | 237.0000 |
netIncome: | 215.5000 |
cashFlow: | 276.8000 |
employees: | 3945 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
year: | 2022 |
cash: | 415.1600 |
balanceSheetTotal: | 2257.2500 |
liabilities: | 1070.0600 |
totalShareholdersEquity: | 1187.1800 |
sales: | 751.4500 |
investment: | 8.3400 |
incomeBeforeTaxes: | -153.9600 |
netIncome: | -175.6600 |
employees: | 4952 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
Finanzen (ausführlich)
year: | 2021 | units: | 1000000 |
balanceSheetTotal: | 2235.2000 | cash: | 699.3000 |
currentAssets: | 1100.9000 | liabilities: | 324.5000 |
totalLiabilitiesEquity: | 2235.2000 | otherLiabilities: | 0.0000 |
provisions: | 75.0000 | totalShareholdersEquity: | 1377.7000 |
employees: | 3945 | property: | 484.6000 |
intangibleAssets: | 30.9000 | longTermInvestments: | 281.9000 |
inventories: | 25.8000 | accountsReceivable: | 132.1000 |
currentSecurities: | 158.9000 | accountsPayable: | 72.6000 |
liabilitiesBanks: | 12.1000 | liabilitiesTotal: | 857.5000 |
shortTermDebt: | 12.1000 | minorityInterests: | 0.0000 |
sales: | 618.0000 | netIncome: | 215.5000 |
operatingResult: | 41.0000 | ebitda: | 41.0000 |
incomeInterest: | -7.0000 | investments: | 72.2000 |
incomeTaxes: | 16.4000 | personnelCosts: | 319.3530 |
costGoodsSold: | 466.5000 | grossProfit: | 151.5000 |
minorityInterestsProfit: | 0.0000 | revenuePerEmployee: | 156653.9924 |
cashFlow: | 122.2000 | cashFlowInvesting: | -243.9000 |
cashFlowFinancing: | 398.4000 | cashFlowTotal: | 276.8000 |
equityRatio: | 61.6365 | debtEquityRatio: | 62.2414 |
liquidityI: | 264.4684 | liquidityII: | 305.1772 |
netMargin: | 34.8706 | grossMargin: | 24.5146 |
cashFlowMargin: | 19.7735 | ebitMargin: | 6.6343 |
ebitdaMargin: | 6.6343 | preTaxROE: | 17.2026 |
preTaxROA: | 10.6031 | roe: | 15.6420 |
roa: | 9.6412 | netIncomeGrowth: | 3320.6349 |
revenuesGrowth: | 23.3779 | taxExpenseRate: | 6.9198 |
equityTurnover: | 0.4486 | epsBasic: | 1.3000 |
epsDiluted: | 1.3000 | epsBasicGrowth: | 3150.0000 |
shareCapital: | 176.6080 | incomeBeforeTaxes: | 237.0000 |
priceEarningsRatioCompany: | 32.6923 | priceCashFlowRatio: | 61.4226 |
dividendYield: | 0.0000 | bookValuePerShare: | 7.8009 |
marketCap: | 7505840000.0000 | earningsYield: | 3.0588 |
pegRatio: | 0.0104 | cashFlowPerShare: | 0.6919 |
netAssetsPerShare: | 7.8009 | priceBookValueRatio: | 5.4481 |
dividendsPerShare: | 0.0000 | priceEarningsRatio: | 34.8299 |
netEarningsPerShare: | 1.2202 | currency: | EUR |
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 2257.2500 | cash: | 415.1600 |
currentAssets: | 1073.6700 | fixedAssets: | 1183.5800 |
liabilities: | 337.7100 | nonCurrentLiabilities: | 732.3600 |
totalLiabilitiesEquity: | 2257.2500 | provisions: | 89.3600 |
totalShareholdersEquity: | 1187.1800 | employees: | 4952 |
property: | 650.2000 | intangibleAssets: | 23.8200 |
longTermInvestments: | 147.1000 | inventories: | 29.8300 |
accountsReceivable: | 168.6500 | accountsPayable: | 97.2800 |
liabilitiesTotal: | 1070.0600 | longTermDebt: | 490.2900 |
shortTermDebt: | 16.3800 | minorityInterests: | 0.0000 |
sales: | 751.4500 | netIncome: | -175.6600 |
operatingResult: | 20.8500 | incomeInterest: | -4.8100 |
investments: | 76.6400 | incomeTaxes: | 21.7000 |
costGoodsSold: | 577.3800 | grossProfit: | 174.1000 |
revenuePerEmployee: | 151746.7690 | cashFlow: | 203.1100 |
cashFlowInvesting: | -415.8200 | cashFlowFinancing: | -52.4100 |
accountingStandard: | IFRS | equityRatio: | 52.5941 |
debtEquityRatio: | 90.1354 | liquidityI: | 122.9339 |
liquidityII: | 172.8732 | netMargin: | -23.3761 |
grossMargin: | 23.1685 | cashFlowMargin: | 27.0291 |
ebitMargin: | 2.7746 | ebitdaMargin: | 0.0000 |
preTaxROE: | -12.9685 | preTaxROA: | -6.8207 |
roe: | -14.7964 | roa: | -7.7820 |
netIncomeGrowth: | -181.5128 | revenuesGrowth: | 21.5939 |
taxExpenseRate: | -14.0946 | equityTurnover: | 0.6330 |
epsBasic: | -0.9900 | epsBasicGrowth: | -176.1538 |
incomeBeforeTaxes: | -153.9600 | priceCashFlowRatio: | 13.2948 |
bookValuePerShare: | 6.7090 | marketCap: | 2700297484.7800 |
earningsYield: | -6.4875 | cashFlowPerShare: | 1.1478 |
netAssetsPerShare: | 6.7090 | priceBookValueRatio: | 2.2745 |
netEarningsPerShare: | -0.9927 | currency: | EUR |
year: | 2023 | priceCashFlowRatio: | 15.5991 |
bookValuePerShare: | 6.7090 | marketCap: | 3168337251.9650 |
earningsYield: | -5.5292 | pegRatio: | 0.1027 |
cashFlowPerShare: | 1.1478 | netAssetsPerShare: | 6.7090 |
priceBookValueRatio: | 2.6688 | netEarningsPerShare: | -0.9927 |
currency: | EUR |
Finanzen (ausführlich)
year: | 2021 |
units: | 1000000 |
balanceSheetTotal: | 2235.2000 |
cash: | 699.3000 |
currentAssets: | 1100.9000 |
liabilities: | 324.5000 |
totalLiabilitiesEquity: | 2235.2000 |
otherLiabilities: | 0.0000 |
provisions: | 75.0000 |
totalShareholdersEquity: | 1377.7000 |
employees: | 3945 |
property: | 484.6000 |
intangibleAssets: | 30.9000 |
longTermInvestments: | 281.9000 |
inventories: | 25.8000 |
accountsReceivable: | 132.1000 |
currentSecurities: | 158.9000 |
accountsPayable: | 72.6000 |
liabilitiesBanks: | 12.1000 |
liabilitiesTotal: | 857.5000 |
shortTermDebt: | 12.1000 |
minorityInterests: | 0.0000 |
sales: | 618.0000 |
netIncome: | 215.5000 |
operatingResult: | 41.0000 |
ebitda: | 41.0000 |
incomeInterest: | -7.0000 |
investments: | 72.2000 |
incomeTaxes: | 16.4000 |
personnelCosts: | 319.3530 |
costGoodsSold: | 466.5000 |
grossProfit: | 151.5000 |
minorityInterestsProfit: | 0.0000 |
revenuePerEmployee: | 156653.9924 |
cashFlow: | 122.2000 |
cashFlowInvesting: | -243.9000 |
cashFlowFinancing: | 398.4000 |
cashFlowTotal: | 276.8000 |
equityRatio: | 61.6365 |
debtEquityRatio: | 62.2414 |
liquidityI: | 264.4684 |
liquidityII: | 305.1772 |
netMargin: | 34.8706 |
grossMargin: | 24.5146 |
cashFlowMargin: | 19.7735 |
ebitMargin: | 6.6343 |
ebitdaMargin: | 6.6343 |
preTaxROE: | 17.2026 |
preTaxROA: | 10.6031 |
roe: | 15.6420 |
roa: | 9.6412 |
netIncomeGrowth: | 3320.6349 |
revenuesGrowth: | 23.3779 |
taxExpenseRate: | 6.9198 |
equityTurnover: | 0.4486 |
epsBasic: | 1.3000 |
epsDiluted: | 1.3000 |
epsBasicGrowth: | 3150.0000 |
shareCapital: | 176.6080 |
incomeBeforeTaxes: | 237.0000 |
priceEarningsRatioCompany: | 32.6923 |
priceCashFlowRatio: | 61.4226 |
dividendYield: | 0.0000 |
bookValuePerShare: | 7.8009 |
marketCap: | 7505840000.0000 |
earningsYield: | 3.0588 |
pegRatio: | 0.0104 |
cashFlowPerShare: | 0.6919 |
netAssetsPerShare: | 7.8009 |
priceBookValueRatio: | 5.4481 |
dividendsPerShare: | 0.0000 |
priceEarningsRatio: | 34.8299 |
netEarningsPerShare: | 1.2202 |
currency: | EUR |
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 2257.2500 |
cash: | 415.1600 |
currentAssets: | 1073.6700 |
fixedAssets: | 1183.5800 |
liabilities: | 337.7100 |
nonCurrentLiabilities: | 732.3600 |
totalLiabilitiesEquity: | 2257.2500 |
provisions: | 89.3600 |
totalShareholdersEquity: | 1187.1800 |
employees: | 4952 |
property: | 650.2000 |
intangibleAssets: | 23.8200 |
longTermInvestments: | 147.1000 |
inventories: | 29.8300 |
accountsReceivable: | 168.6500 |
accountsPayable: | 97.2800 |
liabilitiesTotal: | 1070.0600 |
longTermDebt: | 490.2900 |
shortTermDebt: | 16.3800 |
minorityInterests: | 0.0000 |
sales: | 751.4500 |
netIncome: | -175.6600 |
operatingResult: | 20.8500 |
incomeInterest: | -4.8100 |
investments: | 76.6400 |
incomeTaxes: | 21.7000 |
costGoodsSold: | 577.3800 |
grossProfit: | 174.1000 |
revenuePerEmployee: | 151746.7690 |
cashFlow: | 203.1100 |
cashFlowInvesting: | -415.8200 |
cashFlowFinancing: | -52.4100 |
accountingStandard: | IFRS |
equityRatio: | 52.5941 |
debtEquityRatio: | 90.1354 |
liquidityI: | 122.9339 |
liquidityII: | 172.8732 |
netMargin: | -23.3761 |
grossMargin: | 23.1685 |
cashFlowMargin: | 27.0291 |
ebitMargin: | 2.7746 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -12.9685 |
preTaxROA: | -6.8207 |
roe: | -14.7964 |
roa: | -7.7820 |
netIncomeGrowth: | -181.5128 |
revenuesGrowth: | 21.5939 |
taxExpenseRate: | -14.0946 |
equityTurnover: | 0.6330 |
epsBasic: | -0.9900 |
epsBasicGrowth: | -176.1538 |
incomeBeforeTaxes: | -153.9600 |
priceCashFlowRatio: | 13.2948 |
bookValuePerShare: | 6.7090 |
marketCap: | 2700297484.7800 |
earningsYield: | -6.4875 |
cashFlowPerShare: | 1.1478 |
netAssetsPerShare: | 6.7090 |
priceBookValueRatio: | 2.2745 |
netEarningsPerShare: | -0.9927 |
currency: | EUR |
year: | 2023 |
priceCashFlowRatio: | 15.5991 |
bookValuePerShare: | 6.7090 |
marketCap: | 3168337251.9650 |
earningsYield: | -5.5292 |
pegRatio: | 0.1027 |
cashFlowPerShare: | 1.1478 |
netAssetsPerShare: | 6.7090 |
priceBookValueRatio: | 2.6688 |
netEarningsPerShare: | -0.9927 |
currency: | EUR |